Clinical trials
Children, Only clinical trials
Below are recruiting children, only clinical trials, each written for real people, not researchers. We’re tracking 3,109 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04037761Recruiting
SCHEDULE-P Preschool Study for 3-Year-Olds in Shanghai
This study follows 3-year-old children attending preschools in Shanghai to learn about health, education, and lifestyle patterns. It may help researchers understand what supports healthy development in early childhood.
Shanghai, Shanghai MunicipalityAges 3–6 - NCT07702825Recruiting
MRI study of organ health in teens with obesity
This trial uses MRI scans to check how obesity affects the health of your organs. It may help doctors understand the impact of obesity on the body and find better ways to help teens like you.
Liverpool, MerseysideAges 12–18 - NCT07703488Recruiting
Dydrogesterone for abnormal uterine bleeding in teens
This trial tests if dydrogesterone, a hormone pill, can safely help teenagers with heavy or irregular periods. If you or your child have had unusual bleeding that isn't caused by pregnancy or other medical issues, this study may provide treatment options.
Guangzhou, GuangongAges 10–19 - NCT06289673RecruitingPhase 4
Collecting info to start treatment for new leukemia or lymphoma
This study gathers key health information at the start of treatment for children and teens newly diagnosed with certain types of leukemia or lymphoma. The goal is to find the best way to begin therapy right away, without waiting for extra tests.
San Diego, CaliforniaAges 1–18 - NCT04006808RecruitingPhase 1/Phase 2
Shingles prevention vaccine study for kids with kidney transplants
This study tests whether an investigational shingles (herpes zoster) vaccine is safe and helps prevent shingles in children who have had a kidney transplant. Because these children take medicines to prevent rejection, the study specifically looks at vaccine effects in this higher-risk group.
BrusselsAges 1–17 - NCT04021485Recruiting
Smaller steroid dose test for early-born children’s brain outcomes
This study checks whether giving a lower dose of a steroid medicine (betamethasone) to mothers before birth produces similar brain and thinking outcomes in children born very early (before 32 weeks). It may help reduce medicine exposure while keeping developmental results the same.
Paris, PaAges 5–6 - NCT04026360Recruiting
Study early lung, virus, and gut changes in children with cystic fibrosis
This study looks at how a child’s early lung function, viral infections, and gut (microbiome) changes affect cystic fibrosis over time. It may help doctors understand what predicts how lung disease develops, which could improve future care.
BernAges birth–18 years - NCT04032990Recruiting
Testing a skin-based nerve stimulation for kids’ arm function
This trial studies whether a painless, skin-based treatment (stimulation over the spine) is safe and feasible to improve arm and hand function in children with a spinal cord injury. It’s mainly designed to see if the approach can be done safely and whether it may help upper-limb skills.
Louisville, KentuckyAges 4–18 - NCT04043494RecruitingPhase 3
Study of new treatment plans for childhood lymphoblastic lymphoma
This trial studies a treatment approach for children and teens newly diagnosed with lymphoblastic lymphoma. It may help doctors choose therapies based on genetic risk information from lab testing done on tumor samples.
GrazAges Up to 18 years - NCT04046562Recruiting
Testing a teen pain-and-weight program
This trial studies a program meant to help teens manage weight when they also have ongoing muscle or joint pain. It may help by targeting pain feelings and supporting healthier weight habits at the same time.
Hartford, ConnecticutAges 12–18 - NCT04050995Recruiting
Testing MuSICCA to measure awareness in children
This study tests a tool called MuSICCA to check awareness in children and teens who are being evaluated for a disorder of consciousness. The results may help clinicians better understand a child’s awareness and guide care decisions.
Atlanta, GeorgiaAges 2–18 - NCT04060030RecruitingPhase 2
Leucovorin for young children with autism language difficulties
This Phase 2 study tests whether leucovorin (a vitamin-related medicine) can improve social communication and language in young children with autism. It also looks at safety and whether the results hold while the child stays on their usual therapies and routines.
Phoenix, ArizonaAges 2.5 years–5 years - NCT04065776Recruiting
Proton therapy that avoids the hippocampus for slow brain tumors
This study tests a proton radiation plan designed to spare the hippocampus (a memory area) in children and teens with certain low-grade brain tumors. It may help deliver treatment to the tumor while reducing unwanted brain effects.
Rochester, MinnesotaAges 6–21 - NCT04066465Recruiting
Testing how proton therapy affects thinking in young people
This study looks at how proton radiation therapy may affect thinking, learning, and brain function in children and teens with a primary brain tumor. It uses repeated short brain/learning tests to track possible changes over time.
Dresden, SaxonyAges 8–18 - NCT04068012Recruiting
Test of a decision support tool for children with PARDS
This trial tests a computer “decision support” tool to help the care team manage treatment for children with PARDS who are just starting a breathing machine. It may help clinicians choose care steps and potentially support safer, more effective breathing management during the first days of ventilation.
Chicago, IllinoisAges 1 month–18 years - NCT04084067RecruitingPhase 1
ICG dye helps surgeons remove tumors
This early-phase study tests whether a special dye can help doctors see a tumor more clearly during surgery in children and young people. If you have a solid tumor or certain lymphomas that need removal, the dye may help guide the surgeon to the right tissue.
Memphis, TennesseeAges Any age - NCT04086329RecruitingPhase 1
Testing an oxygen sensor during exercise in muscle disease
This early (Phase 1) study checks whether a tiny oxygen-sensing device works reliably while people with mitochondrial muscle disease (and some healthy volunteers) ride a stationary bike. The goal is to see if the sensor can measure oxygen use during exercise and help future monitoring or research.
Philadelphia, PennsylvaniaAges 18–65 - NCT04091724Recruiting
EEG monitoring during surgery to reduce delirium in children
This study checks whether using an EEG machine (small sensors that record brain electrical activity) during elective surgery can help prevent or lessen emergence delirium—confusion and agitation right after waking up. It focuses on children under 16 and compares their experience around the time they come out of anesthesia.
Wuhan, HubeiAges Up to 16 years - NCT04093986Recruiting
Using past pregnancy records from women with sickle cell
This study looks back at past pregnancy and breastfeeding experiences in women with sickle cell disease who took hydroxyurea. It aims to better understand how hydroxyurea exposure may affect pregnancy and baby outcomes.
Cincinnati, OhioAges Any age - NCT04098445Recruiting
Study of lung injury in children after stem cell transplant
This study follows children and teens who get a stem cell transplant to learn how lung problems develop over time. Your participation could help doctors better predict, prevent, and manage lung injury after transplant.
San Francisco, CaliforniaAges Up to 24 years - NCT04103268Recruiting
Study blood tests to understand organ injury in children with sepsis
This study uses special blood testing to learn what is happening in the immune system during sepsis in children and how it may relate to organ injury. Your results may help doctors recognize and treat sepsis earlier and more accurately.
Boston, MassachusettsAges 1 month–17 years - NCT04103281Recruiting
Blood test study of immune cell markers in ICU sepsis
This trial looks at patterns in certain immune cells (neutrophils) in people with sepsis in the ICU, including those who have a breathing tube. It may help doctors better understand how the immune system changes during sepsis and could guide future care.
Boston, MassachusettsAges 2–50 - NCT04117360Recruiting
Speech therapy study for people after jaw alignment surgery
This study looks at how well people can make specific speech sounds before and after jaw alignment treatment. It may help researchers understand whether speech patterns improve with treatment in people with certain bite differences.
Chapel Hill, North CarolinaAges 15–40 - NCT04119180RecruitingPhase 4
Sedation vs protective positioning for kids' dental work
This study compares two ways of keeping children comfortable and safe during dental treatment: sedation or a protective positioning approach. It may help find which method works better for comfort and safety for children who need fillings or other cavity repair.
Goiânia, GoiásAges 1–7
Hear when a new Children, Only trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for children, only?
- Yes. Clin2 currently lists 3,109 recruiting children, only studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a children, only trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a children, only trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.